Enhancing Capital’s Clorox CLX Stock Holding History

Enhancing Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,000	Closed	-$207K	–	92
2026 Q1	$207K	Hold	2,000	–	–	0.15%	85
2025 Q4	$202K	Hold	2,000	–	–	0.14%	88
2025 Q3	$247K	Hold	2,000	–	–	0.18%	80
2025 Q2	$240K	Hold	2,000	–	–	0.18%	85
2025 Q1	$295K	Hold	2,000	–	–	0.24%	82
2024 Q4	$325K	Buy	+2,000	New	+$327K	0.26%	77
2022 Q3	$252K	Hold	2,000	–	–	0.31%	68
2022 Q2	$282K	Hold	2,000	–	–	0.34%	64
2022 Q1	$278K	Hold	2,000	–	–	0.3%	68
2021 Q4	$349K	Buy	+2,000	New	+$333K	0.38%	59

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Enhancing Capital's CLX Position: Q2 2026 in Review

Enhancing Capital sold out of Clorox (CLX) in Q2 2026, closing a stake of 2,000 shares — an estimated $207K sold.

Enhancing Capital first reported a position in CLX in Q4 2021 and held it in 10 quarters. The position peaked at $349K in Q4 2021. 1,049 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

Enhancing Capital reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
Enhancing Capital sold 2,000 Clorox shares in Q2 2026, an estimated $207K.
Enhancing Capital first reported a position in Clorox in Q4 2021 and held it in 10 quarters.
Enhancing Capital's Clorox position peaked at $349K in Q4 2021.
1,049 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Enhancing Capital's 13F filing for Q2 2026, filed 11 Aug 2026.